Avista Capital Completes Sale of Pathology Laboratory to Fulgent Genetics
Avista Capital Partners, a private equity firm focused on healthcare, closed on the sale of pathology laboratory Inform Diagnostics to Fulgent Genetics.
Read MorePosted by Andy Lundin | Apr 28, 2022 | Anatomic Pathology, Company News |
Avista Capital Partners, a private equity firm focused on healthcare, closed on the sale of pathology laboratory Inform Diagnostics to Fulgent Genetics.
Read MorePosted by Andy Lundin | Apr 14, 2022 | Sexually Transmitted Diseases, Standards |
Few online STI test services in the U.K. meet national recommended standards, with independent sector providers least likely to be compliant.
Read MorePosted by Chris Wolski | Apr 12, 2022 | Blood Gas Analyzers, Covid 19 |
Physicians at the Weiden Clinic implemented a triage system using blood gas testing to diagnose the most severely ill COVID patients.
Read MorePosted by Andy Lundin | Apr 6, 2022 | Calibrators |
Verichem is offering a range of liquid stable and ready-to-use biosynthetic clinical reference materials for use with urine chemistries.
Read MorePosted by Chris Wolski | Apr 5, 2022 | Specimen Collection & Handling |
Dried blood spot testing provides clinical labs an easy-to-collect, reliable, and cost-effective means to test for a variety of diseases.
Read More